Arnold L Oronsky
CIK 1207833 · last filed 2020-10-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MKTO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
467 FIRST STREET SUITE 201
LOS ALTOS, CA 94022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMVP | Director | 6,469,911 | $1.13 | $7.31M | $1.99M | 2 | 2020-10-02 |
| KalVista Pharmaceuticals, Inc. (KALV) Delisted | Director | 388,766 | $27.00 | $10.50M | $1.00M | 6 | 2020-10-02 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Director | 37,506 | $15.50 | $581.3K | $600.0K | 18 | 2020-05-29 |
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | 10%+ Owner | 45,411 | $1.73 | $78.3K | -$17.17M | 1 | 2018-10-22 |
| TESARO, Inc. (TSRO) Delisted | Director | 3,817 | — | — | $10.73M | 10 | 2018-08-09 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Director | 1,404,515 | $0.39 | $552.8K | $0 | 4 | 2017-04-26 |
| MGNX | Director | 1,708,716 | $2.19 | $3.74M | -$7.30M | 3 | 2014-02-18 |
| Marketo, Inc. (MKTO) Delisted | 10%+ Owner | 7,663,756 | — | — | -$637.37M | 1 | 2013-09-18 |
| Trius Therapeutics Inc (TSRX) Delisted | 3,548,643 | — | — | $61.37M | 1 | 2010-08-10 | |
| MBRX | Director | 77 | $7.08 | $546 | $2.32M | 4 | 2009-06-24 |
| ANESIVA, INC. (ANSV) Delisted | Director | 132,388 | — | — | $8.00M | 3 | 2008-05-12 |
| ReShape Weightloss Inc. (ETRM) Delisted | 10%+ Owner | 257,794 | — | — | $0 | 1 | 2007-11-21 |
Recent Filings · Page 3 of 6
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-12-04 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-10-14 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-03 | TESARO, Inc. (TSRO) Delisted | Grant (A) | +1,003 | $0 | EDGAR |
| 2015-05-28 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-14 | — | Mixed | +46,191,960 | $40.50M | |
| 2015-01-14 | TESARO, Inc. (TSRO) Delisted | Other (J) | −598,737 | $0 | EDGAR |
| 2014-12-23 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-18 | MGNX | Sell (S) | −200,000 | -$7.30M | EDGAR |
| 2013-10-30 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Buy (P) | +186,047 | $200.0K | EDGAR |
| 2013-10-18 | MGNX | Mixed | +1,908,716 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.